0001683168-22-000403.txt : 20220124 0001683168-22-000403.hdr.sgml : 20220124 20220124061210 ACCESSION NUMBER: 0001683168-22-000403 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220120 ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220124 DATE AS OF CHANGE: 20220124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RadNet, Inc. CENTRAL INDEX KEY: 0000790526 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133326724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33307 FILM NUMBER: 22547397 BUSINESS ADDRESS: STREET 1: 1510 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 3104787808 MAIL ADDRESS: STREET 1: 1510 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: PRIMEDEX HEALTH SYSTEMS INC DATE OF NAME CHANGE: 19930518 FORMER COMPANY: FORMER CONFORMED NAME: CCC FRANCHISING CORP DATE OF NAME CHANGE: 19920703 8-K 1 radnet_8k.htm FORM 8-K
0000790526 false 0000790526 2022-01-20 2022-01-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): January 20, 2022

_______________________________________________

 

RadNet, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware 001-33307 13-3326724
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number)

 

1510 Cotner Avenue

Los Angeles, CA

 

90025

(Address of principal executive offices) (Zip Code)

 

(310) 478-7808

(Registrant’s Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $.0001 par value RDNT NASDAQ Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

   

 

 

Item 3.02Unregistered Sales of Equity Securities.

 

On January 20, 2022, RadNet, Inc. consummated the acquisition of all of the outstanding equity interests of Aidence Holding B.V. (“Aidence”) and Quantib B.V. (“Quantib”), two unrelated Dutch companies developing software using deep learning artificial intelligence (“AI”) to assist radiologists with reading and interpreting scans.

 

Founded in 2015 and based in Amsterdam, Aidence develops software using deep learning AI to assist with interpreting chest CT images for lung nodule management in the setting of routine imaging and lung cancer screening. Founded in 2012 and based in Rotterdam, Quantib has multiple AI-based solutions with both CE mark and FDA 510(k) clearance, including Quantib Prostate to improve analysis of prostate MRI exams, and Quantib ND and Quantib Brain for analysis of brain MRI exams in the setting of neurodegeneration.

 

The aggregate consideration for the acquisition of Aidence, inclusive of the consideration for future milestones (valued at US$10,000,000) is approximately US$50,000,000. Included in the consideration is the issuance of an aggregate of 1,141,234 shares of RadNet, Inc. common stock to stakeholders of Aidence.

 

The aggregate consideration for the acquisition of Quantib, is approximately US$45,000,000. Included in the consideration is the issuance of an aggregate of 965,058 shares of RadNet, Inc. common stock to the stakeholders of Quantib.

 

In each transaction, the shares of RadNet, Inc. common stock were issued without registration on the basis of the exemptions provided by Regulation S and under Regulation D promulgated under the Securities Act of 1933, as amended. Each recipient of RadNet, Inc. common stock in each transaction was either a non-U.S. person that received the shares in an “offshore transaction” within the meaning of Regulation S, or was an “accredited investor” within the meaning of Rule 501 of Regulation D.

 

RadNet, Inc. issued a combined press release on January 24, 2022, related to the acquisitions. A copy of that press release is attached to this report as Exhibit 99.1.

 

Item 9.01FINANCIAL STATEMENTS AND EXHIBITS.

 

(d) Exhibits

 

Exhibit Number Description of Exhibit
   
99.1 Press Release dated January 24, 2022 related to the acquisition of Aidence Holding B.V. and Quantib B.V.
   
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 2 

 

 

SIGNATURE

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Date: January 24, 2022 RadNet, Inc.  
     
       
  By: /s/ David J. Katz  
  Name: David J. Katz  
  Title:

Executive Vice President, General

Counsel and Corporate Secretary

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 3 

 

 

 

EXHIBIT INDEX

Exhibit Number Description of Exhibit
   
99.1 Press Release dated January 24, 2022 related to the acquisition of Aidence Holding B.V. and Quantib B.V.
   
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 4 

 EX-99.1 2 radnet_ex9901.htm PRESS RELEASE

Exhibit 99.1

 

 

 

 

FOR IMMEDIATE RELEASE

 

RadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V. to Address Opportunities in Lung and Prostate Cancer Diagnosis and Screening with Artificial Intelligence

 

·When combined with RadNet’s existing DeepHealth mammography AI division, the two acquisitions provide RadNet with the basis for future offerings for widespread cancer screening programs for the three most prevalent cancers (breast, prostate and lung)
·Aidence’s AI for chest and lung CT scanning is currently used by customers in seven European countries
·Aidence’s leading product is pending FDA approval for use in the United States
·With customers in 20 countries worldwide, Quantib’s solutions for prostate and brain MRI already have FDA 510(k) clearance in the United States and CE mark in Europe
·Dr. Gregory Sorensen, President of RadNet’s DeepHealth division, will assume leadership responsibility for all of RadNet’s AI initiatives, including those within Aidence and Quantib

 

LOS ANGELES, California, January 24, 2022 – RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 350 owned and operated outpatient imaging centers, today reported that it has acquired two unrelated Dutch technology companies, Aidence Holding B.V., (“Aidence”), a leading radiology artificial intelligence (“AI”) company focusing on clinical solutions for pulmonary nodule management and lung cancer screening and Quantib B.V., (“Quantib”), a leading radiology AI and machine learning company focusing on clinical solutions for prostate cancer and neurodegeneration.

 

Founded in 2015 and based in Amsterdam, Netherlands, Aidence is developing and deploying AI clinical applications to empower interpreting medical images and improving patient outcomes. Aidence’s first commercialized product, Veye Lung Nodules, is an AI-based solution for lung nodule detection and management. This product is CE marked in Europe, where it has a leading position for lung cancer AI screening tools. Aidence’s solution analyzes thousands of CT scans each week, with customers in seven European countries including France, the Netherlands and the United Kingdom (“UK”). In 2020, Aidence received an AI Award to help the UK’s National Health Service improve lung cancer prognosis, and is playing a leading role in large-scale deployments of regional lung cancer screening programs. Aidence’s Veye solution was submitted in December for FDA 510(k) clearance in the United States. Upon successful clearance, Aidence’s solution would be available for use in the United States.

 

Founded in 2012 and based in Rotterdam, Netherlands, Quantib has multiple AI-based solutions with both CE mark and FDA 510(k) clearance, including Quantib Prostate for analysis of prostate MR images and Quantib Brain and Quantib ND to quantify brain abnormalities on MRI. Quantib has customers in more than 20 countries worldwide, including the United States. All of Quantib’s solutions are deployed through Quantib’s AI Node platform which allows for efficient workflow integration and more accelerated regulatory clearance of future products. Quantib Prostate summarizes multiparametric MRI results into an AI “heat map”, which highlights areas of concern, enabling for faster and more accurate diagnosis of prostate disease. Currently, approximately one in every eight men is being diagnosed with prostate cancer in his lifetime, and according to the American Cancer Society estimates, there will be 268,490 new cases of prostate cancer in the United States in 2022. In addition to Quantib Prostate, Quantib Brain and Quantib Brain ND, Quantib is in advanced development of an AI algorithm for MRI of the breast, which could be complementary to Deep Health’s solutions for mammography.

 

 

 

 1 

 

 

Aidence and Quantib will join RadNet’s AI division, formed after the earlier acquisition of DeepHealth in 2020, which to date has focused on breast cancer screening and detection. The acquisitions of Aidence and Quantib will further enable RadNet’s leadership in the development and deployment of AI to improve the care and health of patients.

 

Dr. Howard Berger, Chairman and Chief Executive Officer of RadNet, noted, “We remain convinced that artificial intelligence will have a transforming impact on diagnostic imaging and the field of radiology. We are very pleased to expand our portfolio of AI software into two other cancer screening domains. With the addition of Aidence and Quantib, we will now have effective screening solutions for the three most prevalent cancers. We believe that large population health screening will play an important role for health insurers, health systems and large employer groups in the near future. As the largest owner of diagnostic imaging centers in the United States, RadNet has relationships that can serve to make large-scale screening programs, similar to what mammography is for breast cancer screening, a reality.”

 

Dr. Berger continued, “As we have explained in the past, the benefit of cancer screening for population health is evident, driving improved patient outcomes while lowering costs. Specifically, the data showing the benefit of lung cancer screening with chest CT is robust. While RadNet performs more than 100,000 chest CT scans per year, lung cancer screening is dramatically underutilized, and even more so now that screening guidelines have been expanded to include over 14 million people in the US. Though annual lung cancer screening with low dose CT is recommended for high-risk populations by the US Preventative Services Task Force, too few patients are following the screening guidelines. Furthermore, we believe that lung screening will play an important role for those who suffered from COVID-19 and who may have a requirement to monitor longer-term issues with their lungs. We believe the amount of chest CTs could significantly increase if high-risk patients and patients with long-term COVID-19 effects have access to low-cost, effective screening programs that we believe Aidence’s solutions can facilitate.”

 

“Prostate cancer remains another major cause of morbidity and mortality, and MRI has been shown to have a critical role in the diagnosis and management of prostate cancer. While prostate MRI is a growing area of our overall MRI business, the opportunity to create a lower-cost, more accurate service offering to Medicare and private payors allows for a conversation about creating large-scale screening programs for appropriately-qualified male patient populations, akin to how mammography is utilized today to detect and manage breast disease in women. Quantib’s Prostate solutions further these objectives. Furthermore, Quantib’s commercialized products for brain MRI will be important tools for our business and could have an impact with monitoring Alzheimer’s patients, particularly those who will undergo some of the newer drug and treatment therapies being developed in the marketplace today,” Dr. Berger stated.

 

Mark-Jan Harte, co-founder and CEO of Aidence added, "The Aidence team, my co-founder, Jeroen van Duffelen and I are enthusiastic about joining forces with the RadNet experts. RadNet is a leader in medical imaging and is committed to furthering the use of AI in radiology. Together, we will accelerate our growth and innovation pipeline to serve clinicians with automated and integrated AI solutions for oncology. Our vision is that data is key to improving the prevention, management and treatment of disease. As an outgrowth of operating 350 facilities in some of the busiest and most populous U.S. markets and performing close to nine million exams per year, RadNet’s database of images and radiologist reports is one of the largest and most diverse we have identified. I see unprecedented opportunities to further scale adoption, leveraging RadNet’s capabilities.”

 

Arthur Post Uiterweer, CEO of Quantib noted, "We are thrilled to join the RadNet family. Quantib aims to enable more accurate and efficient clinical decision-making. Being part of RadNet enables us to take a major step towards distributing our solutions and making a much greater impact on patient health and outcomes. We believe our AI Node technology and substantial clinical experience from serving our customers can improve the rate at which future AI innovations are shared across RadNet’s hundreds of locations and the radiology industry at large.”

 

Dr. Berger concluded, “We are excited to add the Aidence and Quantib teams to our AI family. The addition of Aidence and Quantib to our already world-class AI efforts will accelerate the transformation of our business.”

 

 

 

 2 

 

 

Conference Call

 

Dr. Howard Berger, President and CEO of RadNet, Inc., Dr. Gregory Sorensen, President of DeepHealth and head of RadNet’s AI Division, Mark-Jan Harte, Chief Executive Officer of Aidence and Arthur Post Uiterweer, Chief Executive Officer of Quantib, will host a conference call to discuss RadNet’s Artificial Intelligence strategy on Thursday, January 27th, 2022 at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time).

 

Conference Call Details:

 

Date: Thursday, January 27, 2022

Time: 11:00 a.m. Eastern Time

Dial In-Number: 888-254-3590

International Dial-In Number: 929-477-0448

 

It is recommended that participants dial in approximately 5 to 10 minutes prior to the start of the call. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1526026&tp_key=150580c62f

 

An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers, and using the passcode 558728.

 

Forward Looking Statements

 

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Forward-looking statements in this press release include, among others, statements or inferences we make regarding:

 

·Whether Aidence’s and Quantib’s existing or any future products will receive European CE and U.S, FDA510(k) clearance or other regulatory clearance and/or approval necessary for commercialization;
·Whether Aidence’s and Quantib’s existing and any future solutions will prove effective, and whether RadNet’s development and deployment of AI solutions will prove effective for improving the care and health of patients.
·Expected market acceptance for Aidence’s and Quantib’s products and the willingness of customers to use or continue to use Aidence’s and Quantib’s products in the future.
·Aidence’s, Quantib’s and RadNet’s ability to develop, maintain and increase their market positions in a competitive environment.
·Economic benefits and costs savings anticipated to be derived from AI products and solutions, as well as anticipated importance of, and impact of AI solutions, to RadNet’s future business operations.

 

Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated or implied in the forward-looking statements include, those factors, identified in the Annual Report on Form 10-K, Quarterly Report on Form 10-Q and other reports that RadNet, Inc files from time to time with the Securities and Exchange Commission.

 

Any forward-looking statement contained in this press release is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of changed circumstances, new information, future developments or otherwise, except as required by applicable law.

 

 

About RadNet, Inc.

 

RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 350 owned and/or operated outpatient imaging centers. RadNet's markets include California, Maryland, Delaware, New Jersey, New York, Florida and Arizona. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 9,000 employees. For more information, visit http://www.radnet.com.

 

CONTACTS:

RadNet, Inc.

Mark Stolper, 310-445-2800

Executive Vice President and Chief Financial Officer

 GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg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end EX-101.SCH 4 rdnt-20220120.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 rdnt-20220120_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 rdnt-20220120_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.21.4
Cover
Jan. 20, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 20, 2022
Entity File Number 001-33307
Entity Registrant Name RadNet, Inc.
Entity Central Index Key 0000790526
Entity Tax Identification Number 13-3326724
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1510 Cotner Avenue
Entity Address, City or Town Los Angeles
Entity Address, State or Province CA
Entity Address, Postal Zip Code 90025
City Area Code 310
Local Phone Number 478-7808
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $.0001 par value
Trading Symbol RDNT
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 radnet_8k_htm.xml IDEA: XBRL DOCUMENT 0000790526 2022-01-20 2022-01-20 iso4217:USD shares iso4217:USD shares 0000790526 false 8-K 2022-01-20 RadNet, Inc. DE 001-33307 13-3326724 1510 Cotner Avenue Los Angeles CA 90025 310 478-7808 false false false false Common Stock, $.0001 par value RDNT NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.4 html 1 122 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://radnet.com/role/Cover Cover Cover 1 false false All Reports Book All Reports radnet_8k.htm radnet_ex9901.htm rdnt-20220120.xsd rdnt-20220120_lab.xml rdnt-20220120_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "radnet_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "radnet_8k.htm" ] }, "labelLink": { "local": [ "rdnt-20220120_lab.xml" ] }, "presentationLink": { "local": [ "rdnt-20220120_pre.xml" ] }, "schema": { "local": [ "rdnt-20220120.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 122, "memberCustom": 0, "memberStandard": 0, "nsprefix": "RDNT", "nsuri": "http://radnet.com/20220120", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "radnet_8k.htm", "contextRef": "From2022-01-20to2022-01-20", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://radnet.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "radnet_8k.htm", "contextRef": "From2022-01-20to2022-01-20", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://radnet.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 15 0001683168-22-000403-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-22-000403-xbrl.zip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